SIMILAR PATTERNS OF AMINO ACIDS FOR 5AXA_C_ADNC502_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1aua | PHOSPHATIDYLINOSITOLTRANSFER PROTEINSEC14P (Saccharomycescerevisiae) |
PF00650(CRAL_TRIO)PF03765(CRAL_TRIO_N) | 5 | THR A 25ASP A 20LYS A 116ASP A 117LEU A 22 | None | 1.28A | 5axaC-1auaA:undetectable | 5axaC-1auaA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g7r | TRANSLATIONINITIATION FACTORIF2/EIF5B (Methanothermobacterthermautotrophicus) |
PF00009(GTP_EFTU)PF03144(GTP_EFTU_D2)PF11987(IF-2)PF14578(GTP_EFTU_D4) | 5 | LEU A 161ASP A 162ASP A 183MET A 147PHE A 146 | None | 1.19A | 5axaC-1g7rA:2.9 | 5axaC-1g7rA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h3e | TYROSYL-TRNASYNTHETASE (Thermusthermophilus) |
PF00579(tRNA-synt_1b) | 5 | LEU A 269LEU A 243GLY A 242HIS A 52MET A 233 | NoneNoneNoneATP A1433 (-4.3A)None | 1.41A | 5axaC-1h3eA:undetectable | 5axaC-1h3eA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tj7 | ARGININOSUCCINATELYASE (Escherichiacoli) |
PF00206(Lyase_1)PF14698(ASL_C2) | 5 | LEU A 103HIS A 104ASP A 33LEU A 3HIS A 85 | None | 1.40A | 5axaC-1tj7A:undetectable | 5axaC-1tj7A:24.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 54ASP A 134GLU A 200LYS A 230ASP A 234LEU A 389HIS A 398 | ADN A 502 (-4.1A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 3.5A) | 1.49A | 5axaC-1v8bA:55.5 | 5axaC-1v8bA:53.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 53HIS A 54THR A 56ASP A 134GLU A 200LYS A 230ASP A 234LEU A 392GLY A 397HIS A 398MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.26A | 5axaC-1v8bA:55.5 | 5axaC-1v8bA:53.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y23 | HISTIDINE TRIADPROTEIN (Bacillussubtilis) |
PF01230(HIT) | 5 | LEU A 43HIS A 104ASP A 33GLY A 95PHE A 9 | None | 1.21A | 5axaC-1y23A:undetectable | 5axaC-1y23A:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bb0 | IMIDAZOLONEPROPIONASE (Bacillussubtilis) |
PF01979(Amidohydro_1) | 5 | LEU A 103GLU A 223LEU A 301HIS A 272PHE A 221 | None | 1.34A | 5axaC-2bb0A:2.3 | 5axaC-2bb0A:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eh0 | KINESIN-LIKE PROTEINKIF1B (Homo sapiens) |
PF00498(FHA)PF16183(Kinesin_assoc) | 5 | LEU A 11LEU A 48GLY A 36HIS A 57PHE A 60 | None | 1.27A | 5axaC-2eh0A:undetectable | 5axaC-2eh0A:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g1l | KINESIN-LIKE PROTEINKIF1C (Homo sapiens) |
PF00498(FHA)PF16183(Kinesin_assoc) | 5 | LEU A 501LEU A 534GLY A 526HIS A 543PHE A 546 | None | 1.09A | 5axaC-2g1lA:undetectable | 5axaC-2g1lA:12.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hfq | HYPOTHETICAL PROTEIN (Nitrosomonaseuropaea) |
PF09630(DUF2024) | 5 | LEU A 40LYS A 80GLY A 15HIS A 16MET A 18 | None | 1.20A | 5axaC-2hfqA:undetectable | 5axaC-2hfqA:11.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hp3 | IDS-EPIMERASE (Agrobacteriumtumefaciens) |
PF03972(MmgE_PrpD) | 5 | LEU A 263ASP A 91LEU A 104GLY A 159MET A 96 | None | 1.28A | 5axaC-2hp3A:undetectable | 5axaC-2hp3A:22.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.38A | 5axaC-2pqdA:undetectable | 5axaC-2pqdA:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q09 | IMIDAZOLONEPROPIONASE (unidentified) |
PF01979(Amidohydro_1) | 5 | THR A 285GLU A 139ASP A 212LEU A 287HIS A 242 | NoneNoneNoneNone FE A 500 ( 3.5A) | 1.32A | 5axaC-2q09A:2.1 | 5axaC-2q09A:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | HIS A 316THR A 315GLY A 306HIS A 310MET A 263 | NoneGOL A1341 (-3.7A)NoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.29A | 5axaC-2wabA:2.4 | 5axaC-2wabA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xsr | CATECHOL 1,2DIOXYGENASE (Acinetobacterradioresistens) |
PF00775(Dioxygenase_C)PF04444(Dioxygenase_N) | 5 | ASP A 246LEU A 207GLY A 214HIS A 213PHE A 250 | None | 1.33A | 5axaC-2xsrA:undetectable | 5axaC-2xsrA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3azq | AMINOPEPTIDASE (Streptomycesmorookaense) |
PF00326(Peptidase_S9) | 5 | THR A 531ASP A 445LEU A 533GLY A 509PHE A 449 | None | 1.33A | 5axaC-3azqA:3.2 | 5axaC-3azqA:21.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 156GLU A 218LYS A 248ASP A 252LEU A 407 | ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-4.2A) | 1.14A | 5axaC-3ce6A:56.3 | 5axaC-3ce6A:55.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 68HIS A 69THR A 71ASP A 156GLU A 218LYS A 248ASP A 252LEU A 410GLY A 415HIS A 416MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.51A | 5axaC-3ce6A:56.3 | 5axaC-3ce6A:55.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 51ASP A 130GLU A 155LEU A 343HIS A 352 | NoneADN A 438 (-4.1A)ADN A 438 (-3.8A)NAD A 439 ( 4.0A)ADN A 438 ( 3.6A) | 1.34A | 5axaC-3g1uA:61.0 | 5axaC-3g1uA:72.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.46A | 5axaC-3g1uA:61.0 | 5axaC-3g1uA:72.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 5axaC-3glqA:59.0 | 5axaC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 5axaC-3glqA:59.0 | 5axaC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 52ASP A 130GLU A 155LYS A 185ASP A 189LEU A 343HIS A 352 | ADN A 439 ( 4.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 3.3A) | 1.41A | 5axaC-3h9uA:63.3 | 5axaC-3h9uA:72.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155LYS A 185ASP A 189LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.17A | 5axaC-3h9uA:63.3 | 5axaC-3h9uA:72.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54ASP A 132GLU A 192LYS A 222ASP A 226LEU A 378HIS A 387 | NoneADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 (-3.4A) | 1.24A | 5axaC-3n58A:58.8 | 5axaC-3n58A:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 54HIS A 55THR A 57ASP A 132GLU A 192LYS A 222ASP A 226LEU A 381GLY A 386HIS A 387MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.20A | 5axaC-3n58A:58.8 | 5axaC-3n58A:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139GLU A 205LYS A 235ASP A 239LEU A 395HIS A 404 | ADE A 506 (-4.6A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 (-3.4A) | 1.41A | 5axaC-3oneA:55.6 | 5axaC-3oneA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 205LYS A 235ASP A 239LEU A 398GLY A 403HIS A 404MET A 409PHE A 413 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.50A | 5axaC-3oneA:55.6 | 5axaC-3oneA:56.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pf7 | BENZOYL-COAOXYGENASE COMPONENTB (Azoarcusevansii) |
no annotation | 5 | LEU A 427HIS A 423LYS A 398HIS A 406PHE A 395 | None | 0.91A | 5axaC-3pf7A:undetectable | 5axaC-3pf7A:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zu0 | NAD NUCLEOTIDASE (Haemophilusinfluenzae) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | LEU A 139GLU A 128ASP A 94GLY A 98HIS A 46 | NoneNone ZN A1595 (-2.4A)None ZN A1596 (-3.3A) | 1.21A | 5axaC-3zu0A:undetectable | 5axaC-3zu0A:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ct4 | CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT 1 (Homo sapiens) |
PF16415(CNOT1_CAF1_bind) | 5 | LEU A1298GLU A1267ASP A1269LEU A1227GLY A1223 | None | 1.44A | 5axaC-4ct4A:undetectable | 5axaC-4ct4A:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4egx | KINESIN-LIKE PROTEINKIF1A (Homo sapiens) |
PF00498(FHA)PF16183(Kinesin_assoc) | 5 | LEU A 494LEU A 531GLY A 519HIS A 540PHE A 543 | None | 1.12A | 5axaC-4egxA:undetectable | 5axaC-4egxA:18.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ejq | KINESIN-LIKE PROTEINKIF1A (Homo sapiens) |
PF00498(FHA)PF16183(Kinesin_assoc) | 5 | LEU A 494LEU A 531GLY A 519HIS A 540PHE A 543 | None | 1.06A | 5axaC-4ejqA:undetectable | 5axaC-4ejqA:15.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ggv | CYTOCHROME P450SUPERFAMILY PROTEIN (Streptomyceshimastatinicus) |
PF00067(p450) | 5 | LEU A 277THR A 241GLU A 274GLY A 356PHE A 339 | NoneHEM A 401 ( 4.4A)NoneNoneHEM A 401 (-4.7A) | 1.48A | 5axaC-4ggvA:undetectable | 5axaC-4ggvA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kc8 | GLYCOSIDE HYDROLASE,FAMILY 43 (Thermotogapetrophila) |
PF04616(Glyco_hydro_43)PF16369(GH43_C) | 5 | LEU A 440THR A 455GLU A 366HIS A 346PHE A 349 | None | 1.22A | 5axaC-4kc8A:undetectable | 5axaC-4kc8A:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58ASP A 135GLU A 197LYS A 227ASP A 231LEU A 383HIS A 392 | ADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 (-3.5A) | 1.44A | 5axaC-4lvcA:58.2 | 5axaC-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 57HIS A 58THR A 60ASP A 135GLU A 197LYS A 227ASP A 231LEU A 386GLY A 391HIS A 392MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.15A | 5axaC-4lvcA:58.2 | 5axaC-4lvcA:58.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mo9 | PERIPLASMIC BINDINGPROTEIN (Veillonellaparvula) |
PF01497(Peripla_BP_2) | 5 | ASP A 77LEU A 314GLY A 313MET A 78PHE A 82 | None | 1.35A | 5axaC-4mo9A:undetectable | 5axaC-4mo9A:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qiw | DNA-DIRECTED RNAPOLYMERASE (Thermococcuskodakarensis) |
PF00562(RNA_pol_Rpb2_6)PF00623(RNA_pol_Rpb1_2)PF04560(RNA_pol_Rpb2_7)PF04561(RNA_pol_Rpb2_2)PF04563(RNA_pol_Rpb2_1)PF04565(RNA_pol_Rpb2_3)PF04566(RNA_pol_Rpb2_4)PF04567(RNA_pol_Rpb2_5)PF04983(RNA_pol_Rpb1_3)PF04997(RNA_pol_Rpb1_1)PF04998(RNA_pol_Rpb1_5)PF05000(RNA_pol_Rpb1_4) | 5 | LEU B1073HIS A 73LYS B1102ASP B1106GLY A 75 | None ZN A1002 (-3.1A)NoneNoneNone | 1.30A | 5axaC-4qiwB:undetectable | 5axaC-4qiwB:17.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4utg | SUGAR KINASE (Burkholderiapseudomallei) |
PF00288(GHMP_kinases_N)PF08544(GHMP_kinases_C) | 5 | LEU A 198LEU A 14GLY A 15MET A 261PHE A 257 | NoneNone CL A 402 ( 3.7A)NoneNone | 1.25A | 5axaC-4utgA:undetectable | 5axaC-4utgA:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uy6 | HISTIDINE-SPECIFICMETHYLTRANSFERASEEGTD (Mycolicibacteriumsmegmatis) |
PF10017(Methyltransf_33) | 5 | LEU A 167THR A 163GLU A 143ASP A 141GLY A 86 | NoneSAH A 801 ( 3.7A)NoneSAH A 801 (-3.7A)SAH A 801 (-3.0A) | 1.08A | 5axaC-4uy6A:4.3 | 5axaC-4uy6A:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jiu | RAN-BINDING PROTEIN9 (Homo sapiens) |
PF00622(SPRY) | 5 | HIS A 255ASP A 258LEU A 244GLY A 317PHE A 275 | None | 1.38A | 5axaC-5jiuA:undetectable | 5axaC-5jiuA:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | LEU A 95HIS A 92ASP A 146GLY A 51HIS A 186 | NonePO4 A 404 (-3.7A)PO4 A 404 ( 4.6A)None FE A 403 ( 3.4A) | 1.44A | 5axaC-5uq6A:undetectable | 5axaC-5uq6A:22.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 53ASP A 137GLU A 211LYS A 241ASP A 245LEU A 401HIS A 410 | SAH A 502 (-4.0A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 3.5A) | 1.48A | 5axaC-5utuA:53.5 | 5axaC-5utuA:48.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 52HIS A 53THR A 55ASP A 137GLU A 211LYS A 241ASP A 245LEU A 404GLY A 409HIS A 410MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.23A | 5axaC-5utuA:53.5 | 5axaC-5utuA:48.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 59ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386HIS A 395 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 3.4A) | 1.45A | 5axaC-5v96A:57.9 | 5axaC-5v96A:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 59THR A 64ASP A 136ASP A 231HIS A 395 | ADN A 502 ( 3.9A)ADN A 502 (-4.4A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 3.4A) | 1.18A | 5axaC-5v96A:57.9 | 5axaC-5v96A:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 58HIS A 59THR A 61ASP A 136GLU A 197LYS A 227ASP A 231LEU A 389GLY A 394HIS A 395MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.14A | 5axaC-5v96A:57.9 | 5axaC-5v96A:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55THR A 57ASP A 131GLU A 156LYS A 186MET A 358PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNone9W4 A 502 (-3.6A)None | 0.67A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54HIS A 55THR A 57ASP A 131LYS A 186ASP A 190PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)None | 0.73A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54THR A 57ASP A 131LYS A 186ASP A 190HIS A 353PHE A 362 | None9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)None | 0.97A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54THR A 57ASP A 131LYS A 186HIS A 353MET A 358PHE A 362 | None9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.73A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190GLY A 352HIS A 353PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)None | 0.98A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190LEU A 347GLY A 352HIS A 353 | NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A) | 0.97A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186GLY A 352HIS A 353MET A 358PHE A 362 | None9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.74A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186LEU A 347GLY A 352HIS A 353MET A 358 | None9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 0.70A | 5axaC-5w4bA:55.4 | 5axaC-5w4bA:96.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgs | RCC1-LIKE GEXCHANGINGFACTOR-LIKE PROTEIN (Homo sapiens) |
PF00415(RCC1)PF13540(RCC1_2) | 5 | LEU A 187HIS A 185GLY A 255HIS A 241PHE A 244 | None | 1.40A | 5axaC-5xgsA:undetectable | 5axaC-5xgsA:21.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57ASP A 136GLU A 161LYS A 191ASP A 195LEU A 349HIS A 358 | NoneADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 3.5A) | 1.40A | 5axaC-6aphA:63.4 | 5axaC-6aphA:66.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 57HIS A 58THR A 60ASP A 136GLU A 161LYS A 191ASP A 195LEU A 352GLY A 357HIS A 358MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.52A | 5axaC-6aphA:63.4 | 5axaC-6aphA:66.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cey | BIFUNCTIONAL AAC/APH (Staphylococcusaureus) |
no annotation | 5 | LEU A 247ASP A 405GLY A 311HIS A 310PHE A 305 | None | 1.46A | 5axaC-6ceyA:undetectable | 5axaC-6ceyA:13.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61ASP B 139GLU B 164LYS B 194ASP B 198LEU B 373HIS B 382 | ADN B 502 ( 4.0A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 (-3.4A) | 1.41A | 5axaC-6f3mB:57.0 | 5axaC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 11 | HIS B 61THR B 63ASP B 139GLU B 164LYS B 194ASP B 198LEU B 376GLY B 381HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.20A | 5axaC-6f3mB:57.0 | 5axaC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 7 | HIS A 56ASP A 134GLU A 159LYS A 189ASP A 193LEU A 347HIS A 356 | ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 (-3.4A) | 1.43A | 5axaC-6gbnA:63.6 | 5axaC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134GLU A 159ASP A 193 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.7A) | 1.25A | 5axaC-6gbnA:63.6 | 5axaC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | LEU A 55HIS A 56THR A 58ASP A 134GLU A 159LYS A 189ASP A 193LEU A 350GLY A 355HIS A 356MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.15A | 5axaC-6gbnA:63.6 | 5axaC-6gbnA:undetectable |